NCT05142696 2026-03-17A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabNovartisPhase 1/2 Active not recruiting24 enrolled
NCT05468489 2025-10-21To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCShanghai Henlius BiotechPhase 3 Active not recruiting200 enrolled